| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 03/14/2002 | DE10042827A1 Dimerization cofactor of homeodomain proteins as tumor marker, useful for in vitro diagnosis of melanoma |
| 03/14/2002 | DE10042177A1 New acetylcholine receptor subunit, useful for identifying plant-protection and therapeutic agents, comprises segment of insect subunit inserted into vertebrate subunit |
| 03/14/2002 | DE10041766A1 Verfahren zur Markierung chemischer Substanzen Methods for labeling of chemical substances |
| 03/14/2002 | DE10041411A1 Screeningverfahren zur Findung von die Endocytose fördernden Hilfsstoffen Screening method for discovering the endocytosis promoting adjuvants |
| 03/14/2002 | CA2422204A1 Human antibodies against pseudomonas aeruginosa lps derived from transgenic mice |
| 03/14/2002 | CA2422202A1 Modified carbon, silicon and germanium surfaces |
| 03/14/2002 | CA2422114A1 Novel human cancer/testis antigen and gene thereof |
| 03/14/2002 | CA2421922A1 Proteases |
| 03/14/2002 | CA2421912A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | CA2421872A1 Mechanism of mitochondrial membrane permeabilization by hiv-1 vpr, mimetics of vpr and methods of screening active molecules having the ability to alter and/or prevent and/or mimic the interaction of vpr with ant |
| 03/14/2002 | CA2421857A1 Method |
| 03/14/2002 | CA2421834A1 Use of carp inhibitors for the treatment of heart diseases |
| 03/14/2002 | CA2421783A1 Receptor in the edb fibronectin domain |
| 03/14/2002 | CA2421723A1 Stat3 agonists and antagonists and therapeutic uses thereof |
| 03/14/2002 | CA2421581A1 Benzene tricarboxylic acid amides as insulin receptor activators |
| 03/14/2002 | CA2421577A1 Improvements in instruments for measuring the total organic carbon content of water |
| 03/14/2002 | CA2421558A1 Method of monitoring the effect of cathepsin s inhibitors |
| 03/14/2002 | CA2421469A1 Drug discover employing calorimetric target triage |
| 03/14/2002 | CA2421416A1 Description |
| 03/14/2002 | CA2421380A1 Biopanning and rapid analysis of selective interactive ligands (brasil) |
| 03/14/2002 | CA2421368A1 Cellular arrays comprising encoded cells |
| 03/14/2002 | CA2421324A1 Mutant non-human mammal for expressing the alpha6 acetylcholine nicotinic receptor subunit and use for screening substances capable of interacting with said receptor |
| 03/14/2002 | CA2421285A1 Methods for analyzing and using data from hypertensive patients |
| 03/14/2002 | CA2421271A1 Human and mouse targeting peptides identified by phage display |
| 03/14/2002 | CA2421248A1 Test systems based on transmembrane receptors from helminths and the use thereof for identifying and characterizing compounds |
| 03/14/2002 | CA2421218A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | CA2421204A1 Method and system for detecting nucleic acids |
| 03/14/2002 | CA2421203A1 Method and system for identifying commercially distributed organisms |
| 03/14/2002 | CA2421200A1 Adenoviral targeting and manipulation of immune system response using targeting peptides |
| 03/14/2002 | CA2421199A1 Hiv regulatory and auxiliary peptides, antigens, vaccine compositions, immunoassay kit and a method of detecting antibodies induced by hiv |
| 03/14/2002 | CA2421197A1 Generation of combinatorial libraries and assessment thereof by deconvolution |
| 03/14/2002 | CA2421195A1 Compositions and methods for targeting peptides in humans in vivo |
| 03/14/2002 | CA2421193A1 Hiv peptides, antigens, vaccine compositions,immunoassay kit and a method of detecting antibodies induced by hiv |
| 03/14/2002 | CA2421191A1 Methods and compositions for in vitro targeting |
| 03/14/2002 | CA2421187A1 Family member of inhibitor of apoptosis proteins |
| 03/14/2002 | CA2421155A1 Osteoclast-associated receptor |
| 03/14/2002 | CA2421075A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | CA2421070A1 The identification and development of specific monoclonal antibodies to squamous cell carcinoma |
| 03/14/2002 | CA2421027A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 03/14/2002 | CA2420588A1 Polyhydroxyalkanoate levels as an indicator of bioreactor health |
| 03/14/2002 | CA2419983A1 Screening methods to identify compounds that modulate a response of a cell to ultraviolet radiation exposure |
| 03/14/2002 | CA2419966A1 Aryl substituted tetrahydroindazoles and their use as ligands for the gaba-a receptor |
| 03/14/2002 | CA2419456A1 Methods and compositions for producing a neurosalutary effect in a subject |
| 03/14/2002 | CA2416336A1 Multivalent neuraminidase inhibitor conjugates |
| 03/13/2002 | EP1186893A2 Analyzer with sample quality measurement, and method |
| 03/13/2002 | EP1186890A1 Srsv detection kit |
| 03/13/2002 | EP1186889A1 Housing of immunochromatography apparatus |
| 03/13/2002 | EP1186888A1 Microarray fabricating device |
| 03/13/2002 | EP1186878A2 Method and device for LCM (Laser Capture Microdissection) |
| 03/13/2002 | EP1186670A2 Apparatus for measuring the genetic sequence of biopolymers |
| 03/13/2002 | EP1186669A1 Method for specific detection of DNS sequences using parallel amplification |
| 03/13/2002 | EP1186661A1 Identification of the major capacitative calcium channel in antigen presenting cells and uses thereof |
| 03/13/2002 | EP1186660A2 Method for obtaining DNA, RNA, peptides, polypeptides or proteins by means of a DNA-recombination technique |
| 03/13/2002 | EP1186656A1 Method for preparing or removal of circoviruses from biological material |
| 03/13/2002 | EP1186614A2 Crystal structure of the 30S ribosome bound to antibiotics |
| 03/13/2002 | EP1186613A1 New reagent for labelling nucleic acids |
| 03/13/2002 | EP1186299A1 The diagnosis, prevention, and/or succesful treatment of atherosclerosis, infectious diseases, and disturbances in the immune system |
| 03/13/2002 | EP1186059A1 Methods of forming monolayers and uses thereof |
| 03/13/2002 | EP1186048A1 Chip and method for fitting out a chip comprising a plurality of electrodes |
| 03/13/2002 | EP1185948A1 Method for screening and producing compound libraries |
| 03/13/2002 | EP1185873A1 Reporter molecules and methods for assaying high specificity protease activity |
| 03/13/2002 | EP1185872A1 Method for detecting syphilis using synthetic antigens |
| 03/13/2002 | EP1185871A1 Microscale assays and microfluidic devices for transporter, gradient induced, and binding activities |
| 03/13/2002 | EP1185870A1 Bidirectional lateral flow test strip and method |
| 03/13/2002 | EP1185869A2 Ligand-anchor conjugates for producing a biosensor layer |
| 03/13/2002 | EP1185868A1 Analytic sensor apparatus and method |
| 03/13/2002 | EP1185867A2 Method for separating cells using immunorosettes |
| 03/13/2002 | EP1185866A1 A method of determining potential susceptibility to development of alte and/or sids |
| 03/13/2002 | EP1185865A2 Micromechanical antibody sensor |
| 03/13/2002 | EP1185864A1 Protein localization assays for toxicity and antidotes thereto |
| 03/13/2002 | EP1185863A2 Optical system analysis of cells |
| 03/13/2002 | EP1185862A2 Method and compositions relating to insulin resistance disorders |
| 03/13/2002 | EP1185852A1 Method and apparatus for examining fluids of biological origin |
| 03/13/2002 | EP1185851A2 Intrinsic dissolution apparatus with stationary sample holder |
| 03/13/2002 | EP1185712A1 New mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance |
| 03/13/2002 | EP1185710A2 Viral detection method using viral encoded enzymes and chemiluminescent substrates |
| 03/13/2002 | EP1185705A2 Reverse transcriptase assay kit, use thereof and method for analysis of rt activity in biological samples |
| 03/13/2002 | EP1185704A2 Detection system for analyzing molecular interactions, production and utilization thereof |
| 03/13/2002 | EP1185703A2 CoRT-PCR ASSAY FOR THE DISCRIMINATION OF ENDOGENOUS REVERSE TRANSCRIPTASE ACTIVITY IN EUKARYOTIC CELL LINES FROM INFECTIOUS RETROVIRUS CONTAMINATION |
| 03/13/2002 | EP1185699A1 Microarray-based subtractive hybridization |
| 03/13/2002 | EP1185697A2 Assay based on the analysis of dna melting curves |
| 03/13/2002 | EP1185695A1 Process for high throughput dna methylation analysis |
| 03/13/2002 | EP1185694A1 49 human secreted proteins |
| 03/13/2002 | EP1185693A2 Methods for improving sensitivity and specificity of screening assays |
| 03/13/2002 | EP1185692A1 Monolayer and electrode for detecting a label-bearing target and method of use thereof |
| 03/13/2002 | EP1185691A1 Neisseria genomic sequences and methods of their use |
| 03/13/2002 | EP1185690A1 Preparation of stable liquid and dried synthetic prothrombin time reagents |
| 03/13/2002 | EP1185689A1 Reporter molecules and methods for assaying the lipidation status of a cell |
| 03/13/2002 | EP1185688A2 Method and apparatus for enzyme detection |
| 03/13/2002 | EP1185687A1 Methods for increasing t cell proliferation |
| 03/13/2002 | EP1185673A2 Novel calpains and their use |
| 03/13/2002 | EP1185652A2 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 03/13/2002 | EP1185650A1 Head trauma induced cytoplasmatic calcium binding protein |
| 03/13/2002 | EP1185649A2 The myostatin gene promoter and inhibition of activation thereof |
| 03/13/2002 | EP1185646A1 Recombinant nematode nicotinic receptor and uses |
| 03/13/2002 | EP1185645A1 Adipocyte complement related protein homolog zacrp7 |
| 03/13/2002 | EP1185643A1 Adipocyte complement related protein homolog zacrp5 |
| 03/13/2002 | EP1185642A2 Compositions and methods for the treatment of tumor |
| 03/13/2002 | EP1185641A1 Cytokine receptor mouse zcytor10 |
| 03/13/2002 | EP1185640A1 Lipocalin family protein |